Türk Medline
ADR Yönetimi
ADR Yönetimi

TRANEXAMIC ACID IN DERMATOLOGY: EXPLORING ITS ANTIOXIDANT ACTIVITY AND THERAPEUTIC POTENTIAL FOR MELASMA

Merve NENNİ, Tuğba TEHÇİ

Hacettepe University Journal of the Faculty of Pharmacy - 2025;45(4):338-344

Cukurova University, Faculty of Pharmacy, Department of Analytical Chemistry, Adana, Türkiye

 

Melasma, a condition causing uneven brown patches on the forehead, cheeks, and chin, is classified into epidermal, dermal, mixed, and indeterminate types. Treatment options include tranexamic acid (TXAA), which has been increasingly used recently. The 2,2?-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay is a widely accepted and often employed test for quantifying the overall antioxidant capacity of substances. The DPPH method was used to calculate the antioxidant scavenging percentages of TXAA and ascorbic acid (vitamin C). TXAA showed a DPPH radical scavenging activity of 60.77+/-0.34% at 50,000 ppm, while ascorbic acid showed a DPPH radical scavenging activity of 95.77+/-0.59% at 1000 ppm. Ascorbic acid is a known powerful antioxidant. After examining the results, it is clear that TXAA exhibits antioxidant activity, although it is less potent than the antioxidant effect of ascorbic acid.